OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Oncolytic virus delivery modulated immune responses toward cancer therapy: Challenges and perspectives
Mohsen Keshavarz, Seyed Mohammad Miri, Emad Behboudi, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108882-108882
Open Access | Times Cited: 31
Mohsen Keshavarz, Seyed Mohammad Miri, Emad Behboudi, et al.
International Immunopharmacology (2022) Vol. 108, pp. 108882-108882
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
An oncolytic virus–T cell chimera for cancer immunotherapy
Yuxuan Chen, Xiaohong Chen, Weier Bao, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 27
Yuxuan Chen, Xiaohong Chen, Weier Bao, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 27
The Dual Role of Mesenchymal Stem Cells in Cancer Pathophysiology: Pro-Tumorigenic Effects versus Therapeutic Potential
Youssef Slama, Franck Ah-Pine, Mohamed Khettab, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13511-13511
Open Access | Times Cited: 28
Youssef Slama, Franck Ah-Pine, Mohamed Khettab, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13511-13511
Open Access | Times Cited: 28
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 15
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 15
Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy
Matin Ghasemi, Laleh Abbasi, Leila Ghanbari Naeini, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 17
Matin Ghasemi, Laleh Abbasi, Leila Ghanbari Naeini, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 17
Shifting cold to hot tumors by nanoparticle-loaded drugs and products
Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4
Irfan Ahmad, Kamil K. Atiyah Altameemi, Mohaned Mohammed Hani, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 4
The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient
Hangyu Zhang, Yiqing Ren, Feiyu Wang, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 9, pp. 1412-1426
Open Access | Times Cited: 4
Hangyu Zhang, Yiqing Ren, Feiyu Wang, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 9, pp. 1412-1426
Open Access | Times Cited: 4
Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting
Guoshuai Xu, Qinghong Zhang, R. Holland Cheng, et al.
Autophagy (2025)
Open Access
Guoshuai Xu, Qinghong Zhang, R. Holland Cheng, et al.
Autophagy (2025)
Open Access
Nanoengineered immune check point inhibitors delivery for targeted brain cancer treatment: Current status and future perspectives
Juan Liu, Yichao Wang, Zhidu Song, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116789-116789
Closed Access
Juan Liu, Yichao Wang, Zhidu Song, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116789-116789
Closed Access
Unmasking the potential: mechanisms of neuroinflammatory modulation by oncolytic viruses in glioblastoma
Narimene Beder, Seyedeh Nasim Mirbahari, Mourad Belkhelfa, et al.
Exploration of Targeted Anti-tumor Therapy (2025)
Open Access
Narimene Beder, Seyedeh Nasim Mirbahari, Mourad Belkhelfa, et al.
Exploration of Targeted Anti-tumor Therapy (2025)
Open Access
Therapeutic and prognostic values of ferroptosis signature in glioblastoma
Reza Nedaeinia, Hassan Dianat‐Moghadam, Maedeh Movahednasab, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114597-114597
Closed Access
Reza Nedaeinia, Hassan Dianat‐Moghadam, Maedeh Movahednasab, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114597-114597
Closed Access
Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment
Ling Zhang, Seyed Abbas Pakmehr, Reza Shahhosseini, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 9
Ling Zhang, Seyed Abbas Pakmehr, Reza Shahhosseini, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 9
A review exploring the fusion of oncolytic viruses and cancer immunotherapy: An innovative strategy in the realm of cancer treatment
Soumyadeep Chattopadhyay, Rudradeep Hazra, Arijit Mallick, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189110-189110
Closed Access | Times Cited: 3
Soumyadeep Chattopadhyay, Rudradeep Hazra, Arijit Mallick, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189110-189110
Closed Access | Times Cited: 3
Cationic Liposomes Overcome Neutralizing Antibodies and Enhance Reovirus Efficacy in Ovarian Cancer
Zhiru Yang, Liang Chen, Ting Guo, et al.
Virology (2024) Vol. 598, pp. 110196-110196
Closed Access | Times Cited: 2
Zhiru Yang, Liang Chen, Ting Guo, et al.
Virology (2024) Vol. 598, pp. 110196-110196
Closed Access | Times Cited: 2
Involving stemness factors to improve CAR T-cell-based cancer immunotherapy
Sara Abdalrazzaq M. Noraldeen, Irodakhon Rasulova, Repudi Lalitha, et al.
Medical Oncology (2023) Vol. 40, Iss. 11
Closed Access | Times Cited: 4
Sara Abdalrazzaq M. Noraldeen, Irodakhon Rasulova, Repudi Lalitha, et al.
Medical Oncology (2023) Vol. 40, Iss. 11
Closed Access | Times Cited: 4
Advancements and challenges in oncolytic virus therapy for gastrointestinal tumors
Yang Li, Hao-yu Duan, Kaidi Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115627-115627
Open Access | Times Cited: 4
Yang Li, Hao-yu Duan, Kaidi Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115627-115627
Open Access | Times Cited: 4
Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives
Kanaka Dhuri, Sankalp Gharat, Nikita Fernandes, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105365-105365
Closed Access | Times Cited: 1
Kanaka Dhuri, Sankalp Gharat, Nikita Fernandes, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105365-105365
Closed Access | Times Cited: 1
Viral Mimicking Polyplexes as Hierarchical Unpacking Vectors for Rheumatoid Arthritis Treatment
Haofang Zhu, Danqing Huang, Jinglin Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 32
Open Access | Times Cited: 1
Haofang Zhu, Danqing Huang, Jinglin Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 32
Open Access | Times Cited: 1
High-dose vitamin C as a metabolic treatment of cancer: a new dimension in the era of adjuvant and intensive therapy
Xin Wang, Jia He, Minmin Sun, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
Xin Wang, Jia He, Minmin Sun, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
Therapeutic targeting of dormant cancer stem cells in solid tumors
Ghufran Lutfi Ismaeel, Ali Hamid AbdulHussein, Hadeel Qasim, et al.
Gene Reports (2022) Vol. 30, pp. 101717-101717
Closed Access | Times Cited: 7
Ghufran Lutfi Ismaeel, Ali Hamid AbdulHussein, Hadeel Qasim, et al.
Gene Reports (2022) Vol. 30, pp. 101717-101717
Closed Access | Times Cited: 7
Synthesis, Characterization and Application of Hydrogel for cancer treatment
Nidhi Jain, Mona Kejariwal, Faisal Islam Chowdhury, et al.
Chemical Physics Impact (2024) Vol. 9, pp. 100737-100737
Open Access | Times Cited: 1
Nidhi Jain, Mona Kejariwal, Faisal Islam Chowdhury, et al.
Chemical Physics Impact (2024) Vol. 9, pp. 100737-100737
Open Access | Times Cited: 1
NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice
Sahar Sadr-Momtaz, Maryam Aftabi, Emad Behboudi, et al.
BMC Research Notes (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Sahar Sadr-Momtaz, Maryam Aftabi, Emad Behboudi, et al.
BMC Research Notes (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Hepatitis B virus X protein induces expression changes of miR-21, miR-22, miR-122, miR-132, and miR-222 in Huh-7 cell line
Mojtaba Khosravi, Emad Behboudi, Hadi Razavi Nikoo, et al.
Archives of Razi Institute (2023), pp. 111-119
Open Access | Times Cited: 3
Mojtaba Khosravi, Emad Behboudi, Hadi Razavi Nikoo, et al.
Archives of Razi Institute (2023), pp. 111-119
Open Access | Times Cited: 3
NK cells direct the perspective approaches to cancer immunotherapy
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Farah A. Al-Marzook, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Closed Access | Times Cited: 2
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Farah A. Al-Marzook, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Closed Access | Times Cited: 2
Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells
Alborz Soroush, Reza Shahhosseini, Nima Ghavamikia, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Closed Access
Alborz Soroush, Reza Shahhosseini, Nima Ghavamikia, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Closed Access
Comparison of differences in immune cells and immune microenvironment among different kinds of oncolytic virus treatments
Xiaoke Wu, Shaokuan Fang
Frontiers in Immunology (2024) Vol. 15
Open Access
Xiaoke Wu, Shaokuan Fang
Frontiers in Immunology (2024) Vol. 15
Open Access
